|
Volumn 30, Issue SUPPL. 1, 2004, Pages
|
Experience with the IVDD performance evaluations of the ADVIA Centaur infectious disease assays
|
Author keywords
Common Technical Specifications; CTS; EU; European Union; In Vitro Diagnostics; In Vitro Diagnostics Directive; IVD; IVDD; NB; Notified Body
|
Indexed keywords
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS C ANTIBODY;
HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN;
ANTIBODY DETECTION;
ANTIGEN DETECTION;
ARTICLE;
BLOOD SAMPLING;
DIAGNOSTIC ACCURACY;
EUROPE;
HEPATITIS B;
HEPATITIS B VIRUS;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS 2;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOASSAY;
NONHUMAN;
PRIORITY JOURNAL;
VIRUS DIAGNOSIS;
AIDS SERODIAGNOSIS;
AUTOANALYSIS;
CHEMILUMINESCENT MEASUREMENTS;
EUROPE;
HEPATITIS B;
HEPATITIS B SURFACE ANTIGENS;
HEPATITIS C;
HEPATITIS C ANTIBODIES;
HIV ANTIBODIES;
HIV INFECTIONS;
HUMANS;
IMMUNOASSAY;
REPRODUCIBILITY OF RESULTS;
SENSITIVITY AND SPECIFICITY;
|
EID: 1942484342
PISSN: 13866532
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jcv.2004.03.004 Document Type: Article |
Times cited : (2)
|
References (4)
|